News
This will support the advancement of a novel ophthalmic therapeutic through clinical development and onto the market.
From upstream development to late-stage commercialization, outsourcing partners are now a lifeline for biopharma companies ...
Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.
Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...
Ecolab has launched a new resin designed to help achieve cost savings and optimize operations throughout the antibody ...
Advanced technologies and close collaboration maximize yields, safety, and patient access to life-saving therapies.
How specialized expertise, advanced infrastructure, and strategic partnerships are enabling the next generation of cell-based ...
The collaboration aims to advance the discovery and development of novel oral candidates.
Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...
Mitsubishi Research Institute and Astellas have agreed on a memorandum of understanding to provide drug-discovery startups in ...
The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...
TekniPlex Healthcare has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results